v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 41,792 $ 30,321
Accounts receivable 3,080 3,563
Contract assets and unbilled receivables (Note 10) 1,675 2,209
Prepaids and other current assets 1,380 515
Short-term investments 1 2
Total current assets 47,928 36,610
Property and equipment, net 239 252
Total assets 48,167 36,862
Current liabilities:    
Accounts payable 2,430 3,148
Accrued expenses and other liabilities 9,106 8,147
Warrant liabilities 12,715 0
Total current liabilities 24,251 11,295
Total liabilities 24,251 11,295
Commitments and contingencies (Note 3 and Note 9)
Series A preferred stock, par value $0.0001; 14,146 shares were designated as of March 31, 2025 and December 31, 2024; 14,145.374 shares issued and outstanding at March 31, 2025 and December 31, 2024. 18,843 18,843
Stockholders' equity:    
Preferred stock, par value $0.0001; 9,985,854 shares authorized as of March 31, 2025 and December 31, 2024; no shares issued and outstanding at March 31, 2025 and December 31, 2024. 0 0
Common stock, par value $0.0001; 125,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 45,483,823 and 31,574,657 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively. 5 3
Additional paid-in capital 152,260 145,719
Accumulated deficit (147,192) (138,998)
Total stockholders' equity 5,073 6,724
Total liabilities, series A preferred stock, and stockholders' equity $ 48,167 $ 36,862

Source